MENU

DDB issues guidelines to clear jails of illegal drugs

Controlled facilities or jails nationwide are directed to clear its premises from illegal drug activities and secure their drug-cleared or drug-free status, twelve months from now.

Read more ...

DDB responds to the Statement of the UN High Commissioner for Human Rights on the global human rights update

The Dangerous Drugs Board reiterates to the the UN High Commissioner for Human Rights that no policies have to be revoked because there are none which permit, tolerate, and condone killings and other human rights violations in relation to the Philippines’s anti-drug campaign.

Read more ...

DDB provides funding support to Ormoc, BARMM LGU and La Union DOH-TRC

Three beneficiaries received a grant of 5 Million Pesos each from the Dangerous Drugs Board to aid the construction of in-patient and community-based drug treatment and rehabilitation facilities in their respective localities.

Read more ...

Statement of the Dangerous Drugs Board on the Vape Product Containing Marijuana

The Dangerous Drugs Board (DDB) affirms and reiterates the warning issued by the Food and Drug Administration (FDA) against the purchase and use of a vapor product refill, bearing the brand name “Gluttony” and flavor “Mamon,” found to contain cannabinol.

Read more ...

DDB sets regulatory control requirements for Lianhua Qingwen capsules

In emphasizing a balanced national drug control program as a priority, the Dangerous Drugs Board sets the regulatory control requirements for Lianhua Qingwen capsules recently approved by the Food and Drug Administration.

Read more ...

Admission to drug treatment and rehabilitation centers to resume with strict health and safety protocols amid the pandemic

Adjusting to the “New Normal,” the Dangerous Drugs Board (DDB) adopted infection prevention and control protocol to be followed upon the resumption of admissions and activities in drug treatment and rehabilitation facilities nationwide.

Read more ...

DDB issues policy to ensure availability of physicians authorized to assess substance use disorder amid the pandemic

The Dangerous Drugs Board, in its recent special meeting, approved a Resolution extending the validity of provisional accreditation granted to physicians authorized to conduct Drug Dependency Examination (DDE) for a period of two years.

Read more ...

DDB refutes heavy-handed approach in UN-OHCHR drug war report

The Philippine Government takes exception to the Office of the United Nations High Commissioner for Human Rights (OHCHR) Report, especially as it relates to Philippine efforts to effectively address the pervasive menace and destructive effects of illegal drugs in the country.

The Philippines calls on the OHCHR to foster a positive spirit of cooperation with States Parties, with the view of releasing an unbiased report based on facts, legitimate figures and continuing consultations with key anti-drug agencies in the Philippines.

Read more ...

Statement of the DDB on the change of leadership in the Philippine Drug Enforcement Agency

The Dangerous Drugs Board welcomes the assumption of new PDEA Director General Wilkins Villanueva after Malacañang released his appointment signed last 22 May 2020. Incoming DG Villanueva has been a steadfast partner of DDB even during his early years as career officer of PDEA. DDB has involved him in many of its anti-drug efforts particularly in policy formulation and strategy development aspects which helped craft many of its inter-agency priorities all these years. Recognizing him as the 7th Director-General of PDEA, DDB intends to engage more closely and deepen the collaboration with his leadership noting that he will become an Ex-Officio Member of the Board.

Read more ...